Lv5
1400 积分 2023-03-17 加入
With or without sugar? (A)glycosylation of therapeutic antibodies
24分钟前
已完结
The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy
52分钟前
已完结
PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples
2小时前
已完结
Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
3小时前
已完结
Immune-related adverse events associated with immune checkpoint blockade
3小时前
已完结
Allelic variation in HLA‐DRB1 is associated with development of antidrug antibodies in cancer patients treated with atezolizumab that are neutralizing in vitro
1个月前
已关闭
Strategies to Determine Assay Format for the Assessment of Neutralizing Antibody Responses to Biotherapeutics
1个月前
已完结
Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Metastatic Urothelial Carcinoma
1个月前
已完结
Epigenetic regulation of T cell exhaustion in cancer
7个月前
已完结
皖公网安备34019202002308
